📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Mavu Pharma

1.1 - Company Overview

Mavu Pharma Logo

Mavu Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Mavu Pharma

Acceleron Pharma Logo

Acceleron Pharma

HQ: United States Website
  • Description: Provider of novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases; engaged in developing, manufacturing, and commercializing these products, including the ACE-011 program, a novel bone-forming program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acceleron Pharma company profile →
NewBiotics Logo

NewBiotics

HQ: United States Website
  • Description: Provider of drug discovery and development focused on molecules that leverage the cycle of drug resistance in cancer and infectious diseases, transforming drug resistances into therapeutic advantages.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NewBiotics company profile →
Faraday Pharma Logo

Faraday Pharma

HQ: United States Website
  • Description: Provider of early-stage therapeutics targeting ischemia-reperfusion injury, led by FDY-5301, a sodium iodide formulation in Phase 3 to reduce injury after myocardial infarction and potentially decrease heart failure and cardiovascular death. Advancing FDY-8801 for cachexia, and running Iocyte AMI-3 Phase 3 in anterior STEMI PCI; Iocyte AMI Phase 2 completed showing cardiac and inflammatory biomarker reductions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Faraday Pharma company profile →
Prolong Pharmaceuticals Logo

Prolong Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical products and development technologies, including PP-007 (Sanguinate), a PEGylated carboxyhemoglobin bovine product designed to deliver oxygen and carbon monoxide to hypoxic tissues to restore homeostasis and reduce inflammation, and PEGfinity, a PEGylation-based process that enhances the function and stability of therapeutic proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Prolong Pharmaceuticals company profile →
Cephalon Logo

Cephalon

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery, development, and commercialization of medications to improve quality of life worldwide. Founded in 1987, the company delivers first-in-class and best-in-class medicines across several therapeutic areas.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cephalon company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Mavu Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Mavu Pharma

2.2 - Growth funds investing in similar companies to Mavu Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Mavu Pharma

4.2 - Public trading comparable groups for Mavu Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Mavu Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Mavu Pharma

What does Mavu Pharma do?

Mavu Pharma is a provider of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.

Who are Mavu Pharma's competitors?

Mavu Pharma's competitors and similar companies include Acceleron Pharma, NewBiotics, Faraday Pharma, Prolong Pharmaceuticals, and Cephalon.

Where is Mavu Pharma headquartered?

Mavu Pharma is headquartered in United States.

How many employees does Mavu Pharma have?

Mavu Pharma has 1,000 employees 🔒.

When was Mavu Pharma founded?

Mavu Pharma was founded in 2010 🔒.

What sector and industry vertical is Mavu Pharma in?

Mavu Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Mavu Pharma

Who are the top strategic acquirers in Mavu Pharma's sector and industry

Top strategic M&A buyers and acquirers in Mavu Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Mavu Pharma?

Top strategic M&A buyers groups and sectors for Mavu Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Mavu Pharma's sector and industry vertical

Which are the top PE firms investing in Mavu Pharma's sector and industry vertical?

Top PE firms investing in Mavu Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Mavu Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Mavu Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Mavu Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Mavu Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Mavu Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Mavu Pharma?

The key public trading comparables and valuation benchmarks for Mavu Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Mavu Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Mavu Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Mavu Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Mavu Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Mavu Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Mavu Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Mavu Pharma